Dorrilyn Rajbhandari

[The George Institute for Global Health @georgeinstitute]

Update: A/Prof @NaomiHammond received an Honourable mention in the Public Servant of the Year category of the NSW Premier's Awards, announced last night. Well done Naomi!

[Marion Campbell @MarionKCampbell]

I couldn’t agree more. Rob is the brains, the heart and the wonderful soul of the @CritCareReviews venture … a truly phenomenal contribution. Thank you Rob for all that you do! 👇

[Critical Care Reviews @CritCareReviews]

@Lennie333 🙏

[Critical Care Reviews @CritCareReviews]

#REVISEtrial is now published in @NEJM

[Critical Care Reviews @CritCareReviews]

An updated systematic review and meta analysis accompanying #REVISEtrial has just been published in @NEJMEvidence
#CCR24

[NEJM Evidence @NEJMEvidence]

Just published: "Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding — An Updated Meta-Analysis” by Ying Wang, MSc, Deborah Cook, MD, MSc, et al. https://t.co/ip7wXI0rIO

@YaseenarabiYa @DogICUma #CCR24

[Prof Carol Hodgson @chodgsonANZICRC]

JAMA summit on clinical trials also asked us to focus on data infrastructure & integrating it for clinical trials

[The George Institute for Global Health @georgeinstitute]

Another of our Critical Care team's notable studies presented @CritCareReviews this week, showing intensive glucose control did not lower mortality in critically ill adults and increased the risk of severe hypoglycemia.
@naomihammond @LaurentJBillot @OtavioBerwanger

[The George Institute for Global Health @georgeinstitute]

Great to see this impt study showcased @CritCareReviews and published in @JAMA_current!

👉https://t.co/Gpph9k0XEQ, https://t.co/dRBNs8ELAP

@NaomiHammond @DorrilynR @sepsisAU

[Critical Care Reviews @CritCareReviews]

Best trials, best trialists, best editorialists, best delegates all together in one place at the same time #CCR20

[Otavio Berwanger @OtavioBerwanger]

I will be delighted to present during the ESC CRT Plenary: “The Future of Clinical Trials: Towards Diversity and Inclusion” in Vienna. Fantastic event co-chaired by ⁦@hvanspall⁩ and ⁦@FaiezZANNAD⁩ involving trialists, companies and regulators. https://t.co/4FmSjiJBWn

[Roheen Gill @roheengill]

Congratulations @jasonroberts_pk and the team. So amazing work! #UQCCR @UQMedicine

[Gian Luca Di Tanna @GLDiTanna]

I'm thrilled to announce two publications (ohh yesss, using Bayesian Meta Analysis) out on the same day!
1️⃣ In JAMA: https://t.co/L0UrBIJNmF 2️⃣ In NEJMe: https://t.co/HmdBEcvDO1
Great collaborative efforts!

[Paul Young @DogICUma]

The #BLING3 trial is practice-changing. The @WellingtonICU drug manual entry for meropenem has been updated accordingly:
https://t.co/VmggE8YnZt

@CritCareReviews
#CCR24
(we are working on the entry for tazocin)

[Critical Care Reviews @CritCareReviews]

Glycaemic Control IPDMA has just been published in
@NEJMEvidence
https://t.co/fzgQgdkotc
@georgeinstitute

[NEJM Evidence @NEJMEvidence]

Just published: “A Patient-Level Meta-Analysis of Intensive Glucose Control in Critically Ill Adults” by Derick Adigbli, MBBS, PhD, Simon Finfer, MD, et al.: https://t.co/WWiNBer02L

@georgeinstitute #CCR24

[Critical Care Reviews @CritCareReviews]

The BLING III trialists summarise their presentation from CCR24 this morning

Simultaneously published in @JAMA_current

Trial: https://t.co/RW9h28iaZR
SRMA: https://t.co/JyGkEgC0P2
Editorial: https://t.co/7Kgboa9kAs
Interview: https://t.co/SZGolhnYTZ

[JAMA @JAMA_current]

Joel Dulhunty and Jason Roberts join JAMA Deputy Editor @PreetiNMalani to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock. Hosted on @amaedhub. https://t.co/Lv9RjxGXph #CCR24

[Jason Roberts @jasonroberts_pk]

@georgeinstitute @NaomiHammond @DorrilynR @anzics @CritCareReviews @sepsisAU @georgeinstitute is an amazing organisation! Impossible to conduct #Bling3 without their expertise and experience. An honour for us to partner with them @NaomiHammond

[Preeti Malani @PreetiNMalani]

An elegant study that lives up to the BLING III name. Thank you Joel Dulhunty, @jasonroberts_pk and the entire BLING III team for publishing this extraordinary trial in @JAMA_current. #CCR24